These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 29662608

  • 21. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
    Giordano G, Azzoni C, D'Adda T, Rocco A, Gnetti L, Froio E, Merisio C, Melpignano M.
    Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
    [Abstract] [Full Text] [Related]

  • 22. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ.
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
    Sehouli J, Braicu EI, Richter R, Denkert C, Jank P, Jurmeister PS, Kunze CA, Budczies J, Darb-Esfahani S, Schmitt WD, Traut A, Grabowski J, Taube ET, Plett H.
    Hum Pathol; 2019 Mar; 85():299-308. PubMed ID: 30428389
    [Abstract] [Full Text] [Related]

  • 24. Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
    Guan J, Darb-Esfahani S, Richter R, Taube ET, Ruscito I, Mahner S, Woelber L, Prieske K, Concin N, Vergote I, Van Nieuwenhuysen E, Achimas-Cadariu P, Glajzer J, Woopen H, Stanske M, Kulbe H, Denkert C, Sehouli J, Braicu EI.
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1063-1073. PubMed ID: 30810838
    [Abstract] [Full Text] [Related]

  • 25. Is there a relationship in-between ovarian endometriosis and ovarian cancer? Immunohistochemical profile of four cases with coexisting ovarian endometriosis and cancer.
    Penciu RC, Postolache I, Steriu L, Izvoranu S, Tica AA, Mocanu ID, Sârbu V, Deacu M, Tica I, Bălţătescu GI, Tica OS, Tica VI.
    Rom J Morphol Embryol; 2020 Apr; 61(1):157-165. PubMed ID: 32747907
    [Abstract] [Full Text] [Related]

  • 26. A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Voutsadakis IA.
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():172-178. PubMed ID: 33246201
    [Abstract] [Full Text] [Related]

  • 27. Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.
    Camacho-Urkaray E, Santos-Juanes J, Gutiérrez-Corres FB, García B, Quirós LM, Guerra-Merino I, Aguirre JJ, Fernández-Vega I.
    Cell Oncol (Dordr); 2018 Apr; 41(2):213-221. PubMed ID: 29218546
    [Abstract] [Full Text] [Related]

  • 28. The study of p53 and p16 immunoexpression in serous borderline and malignant ovarian tumors.
    Marinaş MC, Mogoş DG, Simionescu CE, Stepan A, Tănase F.
    Rom J Morphol Embryol; 2012 Apr; 53(4):1021-5. PubMed ID: 23303027
    [Abstract] [Full Text] [Related]

  • 29. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
    Assem H, Rambau PF, Lee S, Ogilvie T, Sienko A, Kelemen LE, Köbel M.
    Am J Surg Pathol; 2018 Apr; 42(4):534-544. PubMed ID: 29309296
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
    Gong W, Liu Y, Diamandis EP, Kiechle M, Bronger H, Dorn J, Dreyer T, Magdolen V.
    J Ovarian Res; 2020 Oct 21; 13(1):125. PubMed ID: 33087135
    [Abstract] [Full Text] [Related]

  • 31. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
    Shen XX, Yu L, Bi R, Yang WT.
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug 21; 40(8):511-6. PubMed ID: 22169637
    [Abstract] [Full Text] [Related]

  • 32. CD56 (Neural Cell Adhesion Molecule) Expression in Ovarian Carcinomas: Association With High-Grade and Advanced Stage But Not With Neuroendocrine Differentiation.
    Bösmüller HC, Wagner P, Pham DL, Fischer AK, Greif K, Beschorner C, Sipos B, Fend F, Staebler A.
    Int J Gynecol Cancer; 2017 Feb 21; 27(2):239-245. PubMed ID: 27984374
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I, Cacsire Castillo-Tong D, Vergote I, Ignat I, Stanske M, Vanderstichele A, Ganapathi RN, Glajzer J, Kulbe H, Trillsch F, Mustea A, Kreuzinger C, Benedetti Panici P, Gourley C, Gabra H, Kessler M, Sehouli J, Darb-Esfahani S, Braicu EI.
    Eur J Cancer; 2017 Jul 21; 79():214-225. PubMed ID: 28525846
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO, Pande NT, Buchynska LG.
    Exp Oncol; 2011 Sep 21; 33(3):150-6. PubMed ID: 21956468
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern.
    Lee SH, Kim H, Kim WY, Han HS, Lim SD, Kim WS, Kim S, Hwang TS.
    Pathol Int; 2013 May 21; 63(5):252-9. PubMed ID: 23714252
    [Abstract] [Full Text] [Related]

  • 39. The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
    Köbel M, Kang EY.
    Int J Gynecol Pathol; 2021 Jan 21; 40(1):32-40. PubMed ID: 33290354
    [Abstract] [Full Text] [Related]

  • 40. Outcome and prognostic factors of low‑grade serous ovarian cancer: An observational retrospective study.
    Alhusaini H, Badran A, Al Juhani A, Alshamsan B, Alsagaih Y, Alqayidi AA, Sheikh A, Elhassan T, Maghfoor I, Elshentenawy A, Elshenawy MA.
    Mol Clin Oncol; 2024 Jul 21; 21(1):47. PubMed ID: 38872951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.